DS08210767 is a highly potent, orally bioavailable PTHR1 antagonist with IC50 of 90 nM[1].
[1]. Arai Y, et al. Discovery of novel PTHR1 antagonists: Design, synthesis, and structure activity relationships. Bioorg Med Chem Lett. 2019 Sep 15;29(18):2613-2616.
















